ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO633

It's Not Always Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1302 Glomerular Diseases: Immunology and Inflammation


  • Hardee, Maris, University of Mississippi School of Medicine, Jackson, Mississippi, United States
  • Schwartz, Carter V., The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Dossabhoy, Neville R., The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Caza, Tiffany, Arkana Laboratories, Little Rock, Arkansas, United States
  • Atari, Mohammad, The University of Mississippi Medical Center, Jackson, Mississippi, United States

Systemic lupus erythematosus (SLE) is a complex immunological disease, with a plethora of manifestations. While lupus nephritis commonly affects patients with SLE, other renal diseases may also involve the kidney in SLE patients. Here, we describe a rare case of chronic sclerosing IgA nephropathy in a patient with SLE.

Case Description

A 31-year-old African American female with a history of SLE and secondary Sjogren syndrome presented with dyspnea and pleuritic chest pain. On exam, she had severe hypertension and peripheral edema. Labs were significant for pancytopenia, and creatinine elevated to 2.4 mg/dL (up from a baseline of 1 mg/dL). The urine protein-to-creatinine ratio was 6.57 g/g. Antinuclear antibodies, SSA antibodies, and chromatin antibodies were positive, with a low C3 complement but normal anti-double-stranded DNA antibodies. Kidney biopsy revealed chronic sclerosing IgA nephropathy and arterionephrosclerosis. Global (15/31) and segmental glomerulosclerosis with collapsing features were present. Immunofluorescence showed granular mesangial staining for IgA (+3), IgG (+1), IgM (+2), C3 (+3), kappa and lambda (+2), and negative C1q. Electron microscopy showed focal subendothelial and numerous mesangial electron-dense deposits. The patient declined testing for APOL-1.


The incidence of IgA nephropathy in the setting of SLE is unknown. However, secondary IgA nephropathy has been well described in the setting of Sjogren syndrome. The patient described here presented with nephrotic range proteinuria, elevated creatinine and active systemic lupus, raising concern for lupus nephritis at the time. Kidney biopsy revealed an unexpected glomerular pathology of IgA nephropathy. This case emphasizes the importance of consideration of other etiologies as a cause of renal impairment in SLE patients even with active systemic lupus.